New York State Representative

Maritza Davila 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 35)

Legislative Session

Co-Sponsor of Legislation

NY

New York 2023-2024 Regular Session

New York Assembly Bill A07217

Introduced
5/15/23  
Refer
5/15/23  
Relates to the general hospital indigent care pool and funding for safety net and enhanced safety net hospitals.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07231

Introduced
5/15/23  
Refer
5/15/23  
Relates to duration of orders of protection in cases involving domestic violence.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07235

Introduced
5/15/23  
Refer
5/15/23  
Refer
1/3/24  
Report Pass
5/29/24  
Requires certain documents and forms to be provided in the twelve most common non-English languages spoken by limited English proficient immigrants of five years or less according to the American community survey, as published by the United States census bureau.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07242

Introduced
5/15/23  
Refer
5/15/23  
Allows for no fault separation where the relationship between the spouses has broken down irretrievably for a period of at least six months; requires that issues of support and custody or visitation have been resolved.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07266

Introduced
5/16/23  
Refer
5/16/23  
Relates to establishing speed limits in cities with populations in excess of one million people by easing restrictions so cities can establish speed limits below twenty miles per hour.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07267

Introduced
5/16/23  
Refer
5/16/23  
Designates March twenty-first as a day of commemoration to be known as "Down Syndrome Awareness Day".
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07268

Introduced
5/16/23  
Refer
5/16/23  
Refer
1/3/24  
Report Pass
5/22/24  
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07316

Introduced
5/17/23  
Refer
5/17/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
6/9/23  
Refer
6/9/23  
Expands health care services provided by telehealth to include services delivered through a facility licensed under article twenty-eight of the public health law that is eligible to be designated or has received a designation as a federally qualified health center, including those facilities that are also licensed under article thirty-one or article thirty-two of the mental hygiene law.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07339

Introduced
5/17/23  
Refer
5/17/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
5/31/23  
Refer
5/31/23  
Refer
1/3/24  
Report Pass
6/5/24  
Refer
6/5/24  
Relates to rechargeable battery recycling; adds a battery used as the principal electric power source for an electric scooter or bicycle with electric assist to the definition of "rechargeable battery"; provides that a battery manufacturer may not sell, offer for sale, or distribute rechargeable batteries in the state unless the battery manufacturer is implementing or participating under an approved plan; allows a city with a population of one million or more to enforce through its own agencies.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07407

Introduced
5/19/23  
Refer
5/19/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
6/8/23  
Refer
6/8/23  
Establishes new targets for offshore wind electricity generation; includes the requirements that there is at least 9,900 megawatts of offshore wind electricity generation by 2035, 15,800 megawatts of offshore wind electricity generation by 2040, at least 18,000 megawatts of offshore wind electricity generation by 2045 and at least 20,000 megawatts of offshore wind electricity generation by 2050.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07465

Introduced
5/24/23  
Refer
5/24/23  
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Primary Sponsor of Legislation

NY

New York 2023-2024 Regular Session

New York Assembly Bill A07361

Introduced
5/18/23  
Refer
5/18/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
5/24/23  
Engrossed
5/30/23  
Refer
5/30/23  
Engrossed
6/1/23  
Enrolled
7/13/23  
Chaptered
7/19/23  
Extends current exemptions of income and resources for public assistance programs under the welfare reform act of 1997.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07362

Introduced
5/18/23  
Refer
5/18/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
5/24/23  
Engrossed
5/30/23  
Refer
5/30/23  
Engrossed
6/5/23  
Enrolled
7/13/23  
Chaptered
7/19/23  
Extends provisions relating to enforcement of support obligations through the suspension of driving privileges.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07424

Introduced
5/19/23  
Refer
5/19/23  
Report Pass
5/23/23  
Refer
5/23/23  
Report Pass
5/31/23  
Refer
5/31/23  
Report Pass
6/1/23  
Engrossed
6/1/23  
Refer
6/1/23  
Engrossed
6/7/23  
Enrolled
11/13/23  
Establishes a fiscal cliff task force to conduct a study on fiscal cliffs in the state's public assistance programs and to make recommendations related thereto.
NY

New York 2023-2024 Regular Session

New York Assembly Bill A07451

Introduced
5/22/23  
Refer
5/22/23  
Requires genetic testing results only be received by patients and health care providers providing direct care while health insurance companies only receive a record that the genetic testing was performed; provides insurers cannot require access to genetic testing results and cannot take adverse action against someone for not providing genetic testing results.